Peer-reviewedCC BY-NC-ND 4.0Scientific Reports
Nanoformulated silymarin enhances antifungal activity against resistant Candida albicans by reducing ergosterol and binding to cell envelope targets
Related
- NT-A9, a new triazole, exhibits potent antifungal activity against Candida and Cryptococcus species through potent ergosterol biosynthesis inhibition
- Antifungal-resistant Candida species in healthcare settings: a regional public health strategy
- Vaginal Lactobacillus paragasseri may attenuate fluconazole-resistant phenotypes in the subset of Candida albicans isolates and shows potential as a probiotic adjunct in antifungal therapy
- Dual targeting of EGFR signaling and microtubule dynamics enhances replication-associated cellular stress and suppresses tumor growth in gefitinib-resistant non-small cell lung cancer
- Drug repurposing enhances antibiotic activity in multidrug-resistant staphylococcus aureus through modulation of oxidative stress homeostasis
BibTeX
@article{ghodrati2026nanoformulated,
title = {{Nanoformulated silymarin enhances antifungal activity against resistant Candida albicans by reducing ergosterol and binding to cell envelope targets}},
author = {Melika Ghodrati and Aghil Sharifzadeh and Bahar Nayeri Fasaei and Javad Malakootikhah and Asiyeh Mirzaei Koli and Ali Reza Khosravi},
journal = {Scientific Reports},
year = {2026},
month = oct,
doi = {10.1038/s41598-026-74372-z},
url = {https://www.nature.com/articles/s41598-026-74372-z},
note = {CC BY-NC-ND 4.0},
}
RIS
TY - JOUR
TI - Nanoformulated silymarin enhances antifungal activity against resistant Candida albicans by reducing ergosterol and binding to cell envelope targets
AU - Melika Ghodrati
AU - Aghil Sharifzadeh
AU - Bahar Nayeri Fasaei
AU - Javad Malakootikhah
AU - Asiyeh Mirzaei Koli
AU - Ali Reza Khosravi
PY - 2026
DA - 2026/10/02
JO - Scientific Reports
DO - 10.1038/s41598-026-74372-z
UR - https://www.nature.com/articles/s41598-026-74372-z
SN - 2045-2322
ER -